1. Repository of OAI
Ελληνικά   English  

Browsing by Author Fumoleau, P.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 5 of 5
TitleAuthor(s)Issue date???itemlist.???
Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG)Pavlidis, N.; Aamdal, S.; Awada, A.; Calvert, H.; Fumoleau, P.; Sorio, R.; Punt, C.; Verweij, J.; van Oosterom, A.; Morant, R.; Wanders, J.; Hanauske, A. R.24-Nov-2015-
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development GroupGiaccone, G.; Smit, E. F.; de Jonge, M.; Dansin, E.; Briasoulis, E.; Ardizzoni, A.; Douillard, J. Y.; Spaeth, D.; Lacombe, D.; Baron, B.; Bachmann, P.; Fumoleau, P.24-Nov-2015-
Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development groupBriasoulis, E.; Pavlidis, N.; Terret, C.; Bauer, J.; Fiedler, W.; Schoffski, P.; Raoul, J. L.; Hess, D.; Selvais, R.; Lacombe, D.; Bachmann, P.; Fumoleau, P.24-Nov-2015-
Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancerKerbrat, P.; Dieras, V.; Pavlidis, N.; Ravaud, A.; Wanders, J.; Fumoleau, P.24-Nov-2015-
Phase II trial with S-1 in chemotherapy-naive patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG)Chollet, P.; Schoffski, P.; Weigang-Kohler, K.; Schellens, J. H.; Cure, H.; Pavlidis, N.; Grunwald, V.; De Boer, R.; Wanders, J.; Fumoleau, P.24-Nov-2015-
Showing results 1 to 5 of 5